HIGHLIGHTS
- who: Gabriele Bianco and collaborators from the Microbiology and Virology Unit, University Hospital Cittu00e0 della Salute e della Scienza di Torino, Turin, Italy have published the article: Synergistic Effect of Clinically Available Beta-Lactamase Inhibitors Combined with Cefiderocol against Carbapenemase-Producing Gram-Negative Organisms, in the Journal: Antibiotics 2022, 11, 1681. of /2022/
- what: The aim of this study was to investigate the in vitro impact of clinically on cefiderocol activity against characterized carbapenemaseproducing Gram-negative isolates.
- how: The authors evaluated the in_vitro impact of four different clinical u03b2-lactamase inhibitors on the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.